Taiwan · Delayed Price · Currency is TWD Health & Life Statistics
Total Valuation
Health & Life has a market cap or net worth of TWD 516.74 million. The enterprise value is 475.40 million.
| Market Cap | 516.74M |
| Enterprise Value | 475.40M |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Health & Life has 47.41 million shares outstanding. The number of shares has decreased by -10.87% in one year.
| Current Share Class | 47.41M |
| Shares Outstanding | 47.41M |
| Shares Change (YoY) | -10.87% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 23.56% |
| Owned by Institutions (%) | n/a |
| Float | 34.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.39 |
| PB Ratio | 1.66 |
| P/TBV Ratio | 1.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 90.06 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.24 |
| EV / Sales | 1.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -151.98 |
Financial Position
The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.63.
| Current Ratio | 2.81 |
| Quick Ratio | 1.92 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | n/a |
| Debt / FCF | -63.13 |
| Interest Coverage | -14.02 |
Financial Efficiency
Return on equity (ROE) is -21.46% and return on invested capital (ROIC) is -30.48%.
| Return on Equity (ROE) | -21.46% |
| Return on Assets (ROA) | -7.27% |
| Return on Invested Capital (ROIC) | -30.48% |
| Return on Capital Employed (ROCE) | -16.19% |
| Weighted Average Cost of Capital (WACC) | 4.72% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.84 |
Taxes
| Income Tax | -3.66M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.45% in the last 52 weeks. The beta is 0.25, so Health & Life's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -29.45% |
| 50-Day Moving Average | 11.31 |
| 200-Day Moving Average | 12.18 |
| Relative Strength Index (RSI) | 50.94 |
| Average Volume (20 Days) | 52,931 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Health & Life had revenue of TWD 372.93 million and -76.18 million in losses. Loss per share was -1.61.
| Revenue | 372.93M |
| Gross Profit | 48.84M |
| Operating Income | -82.30M |
| Pretax Income | -79.84M |
| Net Income | -76.18M |
| EBITDA | -72.23M |
| EBIT | -82.30M |
| Loss Per Share | -1.61 |
Balance Sheet
The company has 238.82 million in cash and 197.47 million in debt, with a net cash position of 41.34 million or 0.87 per share.
| Cash & Cash Equivalents | 238.82M |
| Total Debt | 197.47M |
| Net Cash | 41.34M |
| Net Cash Per Share | 0.87 |
| Equity (Book Value) | 311.65M |
| Book Value Per Share | 6.57 |
| Working Capital | 280.88M |
Cash Flow
In the last 12 months, operating cash flow was 5.74 million and capital expenditures -8.87 million, giving a free cash flow of -3.13 million.
| Operating Cash Flow | 5.74M |
| Capital Expenditures | -8.87M |
| Depreciation & Amortization | 10.07M |
| Net Borrowing | -18.67M |
| Free Cash Flow | -3.13M |
| FCF Per Share | -0.07 |
Margins
Gross margin is 13.10%, with operating and profit margins of -22.07% and -20.43%.
| Gross Margin | 13.10% |
| Operating Margin | -22.07% |
| Pretax Margin | -21.41% |
| Profit Margin | -20.43% |
| EBITDA Margin | -19.37% |
| EBIT Margin | -22.07% |
| FCF Margin | n/a |
Dividends & Yields
Health & Life does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 10.87% |
| Shareholder Yield | 10.87% |
| Earnings Yield | -14.74% |
| FCF Yield | -0.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 14, 2006. It was a forward split with a ratio of 1.0314.
| Last Split Date | Sep 14, 2006 |
| Split Type | Forward |
| Split Ratio | 1.0314 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |